Gastroparesis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global gastroparesis drugs market size reached US$ 5.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2027, exhibiting a growth rate (CAGR) of 5.15% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Gastroparesis, also known as stomach paralysis, is a medical condition that affects the normal and spontaneous movement of the muscles in the stomach. It interferes with the digestion process and causes nausea, vomiting, abdominal pain, and problems with maintaining blood sugar levels and nutrition absorption. At present, it is treated under the guidance of doctors using drugs, such as domperidone, metoclopramide, erythromycin, diphenhydramine, ondansetron, and prochlorperazine.
Gastroparesis Drugs Market Trends:
Due to rapid urbanization, sedentary lifestyles and the growing number of individuals who drink and smoke regularly, there is a significant rise in the prevalence of diabetes across the globe. This, in confluence with the increasing geriatric population, which is relatively more susceptible to developing gastroparesis, represents one of the key factors bolstering the growth of the market. In addition, gastroparesis drugs aid in enhancing gastrointestinal motility by improving the frequency of contraction. As a result, they are extensively being utilized for treating idiopathic gastroparesis, which causes severe vomiting, nausea, and upper abdominal pain. This, along with a considerable rise in the number of individuals developing gastroparesis after the vague nerve and its branches are damaged via surgical operations, are also contributing to market growth. Furthermore, leading manufacturers are continuously funding research and development (R&D) projects to introduce new approaches to the existing drug therapy. They are also developing advanced and effective drugs that can be administered via the nasal cavity for individuals who are experiencing symptoms of gastroparesis, which is creating a favorable market outlook. Other major factors, including the improving healthcare infrastructure and the escalating demand for user-friendly drugs, are anticipated to impel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastroparesis drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on disease type, drug class and distribution channel.
Breakup by Disease Type:
Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Others
Breakup by Drug Class:
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections
Breakup by Distribution Channel:
Hospitals and Clinics
Pharmacies
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abbvie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Becton Dickinson and Company, Boston Scientific Corporation, Evoke Pharma, Medtronic plc, Neurogastrx Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Theravance Biopharma.
Key Questions Answered in This Report:
How has the global gastroparesis drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global gastroparesis drugs market?
What are the key regional markets?
What is the breakup of the market based on the disease type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global gastroparesis drugs market and who are the key players?
What is the degree of competition in the industry?
Gastroparesis, also known as stomach paralysis, is a medical condition that affects the normal and spontaneous movement of the muscles in the stomach. It interferes with the digestion process and causes nausea, vomiting, abdominal pain, and problems with maintaining blood sugar levels and nutrition absorption. At present, it is treated under the guidance of doctors using drugs, such as domperidone, metoclopramide, erythromycin, diphenhydramine, ondansetron, and prochlorperazine.
Gastroparesis Drugs Market Trends:
Due to rapid urbanization, sedentary lifestyles and the growing number of individuals who drink and smoke regularly, there is a significant rise in the prevalence of diabetes across the globe. This, in confluence with the increasing geriatric population, which is relatively more susceptible to developing gastroparesis, represents one of the key factors bolstering the growth of the market. In addition, gastroparesis drugs aid in enhancing gastrointestinal motility by improving the frequency of contraction. As a result, they are extensively being utilized for treating idiopathic gastroparesis, which causes severe vomiting, nausea, and upper abdominal pain. This, along with a considerable rise in the number of individuals developing gastroparesis after the vague nerve and its branches are damaged via surgical operations, are also contributing to market growth. Furthermore, leading manufacturers are continuously funding research and development (R&D) projects to introduce new approaches to the existing drug therapy. They are also developing advanced and effective drugs that can be administered via the nasal cavity for individuals who are experiencing symptoms of gastroparesis, which is creating a favorable market outlook. Other major factors, including the improving healthcare infrastructure and the escalating demand for user-friendly drugs, are anticipated to impel the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global gastroparesis drugs market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on disease type, drug class and distribution channel.
Breakup by Disease Type:
Diabetic Gastroparesis
Idiopathic Gastroparesis
Post-surgical Gastroparesis
Others
Breakup by Drug Class:
Prokinetic Agents
Antiemetic Agents
Botulinum Toxin Injections
Breakup by Distribution Channel:
Hospitals and Clinics
Pharmacies
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abbvie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Becton Dickinson and Company, Boston Scientific Corporation, Evoke Pharma, Medtronic plc, Neurogastrx Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Theravance Biopharma.
Key Questions Answered in This Report:
How has the global gastroparesis drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global gastroparesis drugs market?
What are the key regional markets?
What is the breakup of the market based on the disease type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global gastroparesis drugs market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL GASTROPARESIS DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DISEASE TYPE
6.1 Diabetic Gastroparesis
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Idiopathic Gastroparesis
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Post-surgical Gastroparesis
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY DRUG CLASS
7.1 Prokinetic Agents
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Antiemetic Agents
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Botulinum Toxin Injections
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Abbvie Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 AstraZeneca Plc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bausch Health Companies Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Becton Dickinson and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Boston Scientific Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Evoke Pharma
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Neurogastrx Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Takeda Pharmaceutical Company Limited
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Theravance Biopharma
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL GASTROPARESIS DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DISEASE TYPE
6.1 Diabetic Gastroparesis
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Idiopathic Gastroparesis
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Post-surgical Gastroparesis
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 MARKET BREAKUP BY DRUG CLASS
7.1 Prokinetic Agents
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Antiemetic Agents
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Botulinum Toxin Injections
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Abbvie Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 AstraZeneca Plc
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bausch Health Companies Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Becton Dickinson and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Boston Scientific Corporation
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Evoke Pharma
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Neurogastrx Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sanofi S.A.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Takeda Pharmaceutical Company Limited
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Theravance Biopharma
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Gastroparesis Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Gastroparesis Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 3: Global: Gastroparesis Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 4: Global: Gastroparesis Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Gastroparesis Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Gastroparesis Drugs Market: Competitive Structure
Table 7: Global: Gastroparesis Drugs Market: Key Players
Table 1: Global: Gastroparesis Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Gastroparesis Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 3: Global: Gastroparesis Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 4: Global: Gastroparesis Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Gastroparesis Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Gastroparesis Drugs Market: Competitive Structure
Table 7: Global: Gastroparesis Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Gastroparesis Drugs Market: Major Drivers and Challenges
Figure 2: Global: Gastroparesis Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Gastroparesis Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Gastroparesis Drugs Market: Breakup by Disease Type (in %), 2021
Figure 5: Global: Gastroparesis Drugs Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Gastroparesis Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Gastroparesis Drugs Market: Breakup by Region (in %), 2021
Figure 8: Global: Gastroparesis Drugs (Diabetic Gastroparesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Gastroparesis Drugs (Diabetic Gastroparesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Gastroparesis Drugs (Idiopathic Gastroparesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Gastroparesis Drugs (Idiopathic Gastroparesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Gastroparesis Drugs (Post-surgical Gastroparesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Gastroparesis Drugs (Post-surgical Gastroparesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Gastroparesis Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Gastroparesis Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Gastroparesis Drugs (Prokinetic Agents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Gastroparesis Drugs (Prokinetic Agents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Gastroparesis Drugs (Antiemetic Agents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Gastroparesis Drugs (Antiemetic Agents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Gastroparesis Drugs (Botulinum Toxin Injections) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Gastroparesis Drugs (Botulinum Toxin Injections) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Gastroparesis Drugs (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Gastroparesis Drugs (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Gastroparesis Drugs (Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Gastroparesis Drugs (Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Gastroparesis Drugs (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Gastroparesis Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Gastroparesis Drugs Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Gastroparesis Drugs Industry: SWOT Analysis
Figure 78: Global: Gastroparesis Drugs Industry: Value Chain Analysis
Figure 79: Global: Gastroparesis Drugs Industry: Porter's Five Forces Analysis
Figure 1: Global: Gastroparesis Drugs Market: Major Drivers and Challenges
Figure 2: Global: Gastroparesis Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Gastroparesis Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Gastroparesis Drugs Market: Breakup by Disease Type (in %), 2021
Figure 5: Global: Gastroparesis Drugs Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Gastroparesis Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Gastroparesis Drugs Market: Breakup by Region (in %), 2021
Figure 8: Global: Gastroparesis Drugs (Diabetic Gastroparesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Gastroparesis Drugs (Diabetic Gastroparesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Gastroparesis Drugs (Idiopathic Gastroparesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Gastroparesis Drugs (Idiopathic Gastroparesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Gastroparesis Drugs (Post-surgical Gastroparesis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Gastroparesis Drugs (Post-surgical Gastroparesis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Gastroparesis Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Gastroparesis Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Gastroparesis Drugs (Prokinetic Agents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Gastroparesis Drugs (Prokinetic Agents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Gastroparesis Drugs (Antiemetic Agents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Gastroparesis Drugs (Antiemetic Agents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Gastroparesis Drugs (Botulinum Toxin Injections) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Gastroparesis Drugs (Botulinum Toxin Injections) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Gastroparesis Drugs (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Gastroparesis Drugs (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Gastroparesis Drugs (Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Gastroparesis Drugs (Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Gastroparesis Drugs (Online Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Gastroparesis Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Gastroparesis Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Gastroparesis Drugs Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Gastroparesis Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Gastroparesis Drugs Industry: SWOT Analysis
Figure 78: Global: Gastroparesis Drugs Industry: Value Chain Analysis
Figure 79: Global: Gastroparesis Drugs Industry: Porter's Five Forces Analysis
